A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
119-SRES-732119th CongressIntroduced May 14, 2026
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310)
Sponsor
Sen. Warren, Elizabeth [D-MA](D-MA)46 cosponsors
Actions (2)
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310)
May 14, 2026Senate
Submitted in Senate
May 14, 2026Library of Congress